EX-2.1
from 8-K
85 pages
Confidential Portions Have Been Omitted Based Upon a Request for Confidential Treatment Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934 and Have Been Separately Filed With the Securities and Exchange Commission. Agreement and Plan of Merger and Reorganization Among: Clarient, Inc., Clarient Acquisition Corporation, Applied Genomics, Inc., Certain Stockholders of Applied Genomics, Inc., and Robert S. Seitz, as Stockholders’ Representative Dated as of December 21, 2009
12/34/56